Da der ikke findes nogen data om nyfødte, der udsættes for laronidase via modermælk, anbefales det at afbryde amning under behandling med Aldurazyme.
Because there are no data available in neonates exposed to laronidase via breast milk, it is recommended to stop breast-feeding during Aldurazyme treatment.